It may include fertility evaluation, assessment of the gestational carrier, IVF and embryo-transfer planning, pregnancy monitoring, delivery preparation, postpartum care and access to counselling. The precise plan depends on individual circumstances and local requirements.

Care may involve a fertility specialist, embryology laboratory team, obstetrician, relevant medical specialists, counsellor or mental-health professional, pediatrician and independent legal adviser. The team should clarify each professional’s role.

Gestational surrogacy involves transferring an embryo created through IVF into a carrier’s uterus. The carrier does not provide the egg, so she has no genetic relationship to the child through the egg.

Traditional surrogacy involves the surrogate’s own egg, making her genetically related to the child. It raises distinct medical, ethical and legal issues, and its availability or legality varies by jurisdiction.

People may explore it when pregnancy is medically contraindicated, not possible, or unsuccessful after treatment, among other circumstances. Whether a person can legally access surrogacy depends on the jurisdiction and current rules.

A consultation with a qualified fertility specialist is an important part of understanding medical options, possible causes of infertility, treatment choices and whether surrogacy is appropriate to consider.

Discuss reproductive and pregnancy history, previous fertility treatment, surgeries, current and past illnesses, medicines, allergies, family history and any prior pregnancy complications. Share information accurately and ask how it will be protected.

Tests may include blood work, infection screening, imaging, fertility-related investigations and other assessments selected for the people involved. There is no single universal test panel suitable for everyone.

No. Investigations depend on the source of eggs and sperm, prior results, medical history, treatment plans and relevant regulations. Ask the clinician why each test is recommended.

The assessment helps the care team review whether pregnancy and the proposed treatment may pose particular risks, identify issues requiring further evaluation and plan appropriate care. It should be individualized and respectful.

In vitro fertilization is a process in which eggs and sperm are brought together in a laboratory to create embryos. An embryo may then be transferred or cryopreserved, depending on the treatment plan and clinical circumstances.

Intracytoplasmic sperm injection is a laboratory technique in which a single sperm is injected into an egg. A specialist may recommend it for selected clinical or laboratory indications; it is not necessary in every IVF cycle.

When egg retrieval is part of treatment, the ovaries are stimulated and eggs are collected using a procedure performed by the clinical team, commonly with ultrasound guidance and sedation or anesthesia as appropriate. The team should explain preparation, risks and recovery.

Not necessarily. Depending on the circumstances, previously frozen eggs or embryos may be considered. Availability, consent, storage arrangements, medical suitability and legal requirements must be reviewed.

Embryo culture is the period during which embryos are maintained and observed in the IVF laboratory. Development varies, and not every embryo reaches a stage suitable for transfer or freezing.

A frozen embryo transfer uses an embryo that was cryopreserved earlier and subsequently thawed for transfer. The clinic plans the timing and preparation protocol according to the carrier’s circumstances.

Embryo transfer is generally performed by passing a thin catheter through the cervix into the uterus. It usually does not require abdominal surgery, but the clinic should explain the procedure and any individualized considerations.

No. Implantation and pregnancy are not guaranteed. Outcomes depend on several factors, including embryo characteristics, uterine and medical factors, and other variables. The fertility team can discuss the limits of available estimates.

The number should be determined through individualized clinical discussion and applicable standards. Transferring more than one embryo can increase the chance of multiple pregnancy, which carries additional risks for the carrier and babies.

Multiple pregnancy means carrying more than one fetus. It is associated with increased risks, including preterm birth and certain maternal complications. Ask the fertility team how the treatment plan addresses these risks.

The clinic provides instructions about medicines, testing dates, symptoms and follow-up. Continue or change medications only as directed by the treating team, and contact them if symptoms or concerns arise.

The clinic will specify when to test based on the treatment protocol. Testing too early can be misleading, so follow the schedule provided rather than relying on an arbitrary date.

The timing is determined by the fertility and obstetric team. Ultrasound helps assess the pregnancy’s location and development, but the appropriate timing depends on the clinical situation.

The carrier needs routine prenatal care and additional assessments when indicated by her medical history or pregnancy. Her obstetric team should provide a schedule for visits, screening, scans and urgent contact.

Care is individualized. Some pregnancies may require additional monitoring because of the treatment history, maternal health, multiple gestation or other factors. The obstetric team determines what is appropriate.

Potential complications can include miscarriage, ectopic pregnancy, hypertensive disorders, gestational diabetes, preterm birth and delivery-related complications. Individual risk varies, so discuss personal risk factors and warning signs with the clinician.

Medication use should be reviewed with the treating clinicians. Do not stop, start or change prescription medicines, over-the-counter products or supplements without appropriate medical advice.

Seek urgent care for severe pain, heavy bleeding, fainting, chest pain, difficulty breathing, severe headache, visual changes or other symptoms identified by the maternity team as urgent. Follow local emergency guidance.

The gestational carrier is the person receiving medical care and should provide informed consent for her treatment. Intended parents may be involved in discussions as agreed, but should not override her medical autonomy.

Informed consent means understanding the proposed procedure, expected benefits, material risks, alternatives and the option to ask questions or decline. Consent should be voluntary and obtained without coercion.

Psychological counselling can help participants consider expectations, communication, uncertainty, stress and emotional needs. The availability and requirements for counselling vary, but access to supportive, independent care can be valuable.

Independent legal advice helps the carrier understand the arrangement, rights, responsibilities and relevant documents without relying solely on another participant’s adviser. Specific legal requirements vary by jurisdiction.

Postpartum care is medical and emotional support after delivery. It includes assessment of recovery, management of complications when present, discussion of physical and mental well-being, and guidance about follow-up.

Yes. A newborn should receive appropriate newborn and pediatric care, including assessment after birth and follow-up according to the baby’s health and local clinical guidance.

Participation should be agreed with the carrier and clinical team, respecting privacy, consent, clinic policies and the carrier’s preferences. The carrier’s care and comfort remain central.

Participants should agree on communication arrangements that respect confidentiality, consent and applicable privacy laws. The clinic can explain what information may be shared and how records are handled.

A birth plan may cover the intended place of delivery, clinical contingencies, support people, communication preferences and coordination with the newborn team. It should remain flexible and defer to urgent medical needs.

No. The mode of delivery depends on obstetric indications and the clinical circumstances. Surrogacy alone does not mean that every birth must be by cesarean; discuss the plan with the obstetrician.

Any pregnancy can involve complications. The care team assesses the carrier’s health, obstetric history and current pregnancy to determine whether additional monitoring or specialist care is needed.

The fertility team can review the cycle, explain what is known and uncertain, and discuss whether further evaluation or another approach is reasonable. A failed cycle should not be interpreted as a personal failure.

Embryo cryopreservation may be an option when clinically suitable and legally permitted. The clinic should explain storage, consent, fees, duration, disposition decisions and how future use is authorized.

Preimplantation genetic testing refers to laboratory testing of cells associated with embryos for selected genetic or chromosomal purposes. Whether it is indicated, what it can detect and its limitations should be discussed with qualified specialists.

No. Testing has limitations and cannot guarantee a child will be free of all genetic conditions, congenital anomalies or health problems. A genetic counsellor or fertility specialist can explain the scope and limitations of a proposed test.

Discuss medical screening, genetic considerations, consent, identity and record policies, counselling, and applicable legal rules. Donor arrangements and permitted practices differ by jurisdiction.

No. Laws differ substantially between countries and sometimes within regions. Some jurisdictions prohibit certain arrangements or impose eligibility and documentation requirements. Obtain current local legal advice before proceeding.

They should review current requirements under Indian surrogacy and ART legislation, rules and notifications with a registered clinic and qualified legal professional. Official information is available through the National ART & Surrogacy Portal and India Code.

Consult the National ART & Surrogacy Portal, its rules and notifications, and the Surrogacy (Regulation) Act, 2021. Verify that you are consulting the current version.

Consider counselling, a trusted support network, clear communication, realistic expectations and a plan for uncertainty or difficult outcomes. Each participant should have space to express concerns and seek independent support.

Ask about the proposed pathway, medical eligibility, investigations, treatment risks, alternatives, success-rate definitions, embryo-transfer policy, costs, consent, counselling, privacy, emergency arrangements and the clinic’s registration or regulatory status.

Start with a consultation with a qualified fertility specialist and obtain independent legal advice relevant to your jurisdiction. Gather your medical history, write down questions and make sure everyone involved can access clear information and voluntary, informed support.